Type 2 diabetes treatment plans: understanding dealbreakers for patients

A case study on patient preferences and shared decision-making
2
23 March 2022
Save
ClosePlease login
deal breaker

By Dr Gary Kilov

Patient preference should be a major factor in driving the choice of glucose-lowering medications to treat type 2 diabetes.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .